Rapid Science is a nonprofit organization aiming to speed translational science, its accuracy, its dissemination to the clinic, and feedback regarding its efficacy. Our products and services include:
- practical social media tools for multi-institutional groups to share research results
- facilitation by subject experts who curate discussions and content
- “organic” peer review citing incremental research in context with the published evidence
- smooth transition from closed discussion to open dissemination
- iteration of results at every stage
- reward metrics that can be used alongside the current “publish or perish” system – to gauge effective collaboration.
We’re piloting in fields of biomedicine, where data sharing and rapid exchange of findings between the lab and clinic can have immediate benefits for patients and for translational research. The Rapid Science platform will be the first truly dynamic research venue where the act of publishing is incidental to the search for faster, better cures.
Board of Directors
Bruce Alberts, PhD
Bruce is a biochemist at University of California, San Francisco, known for his work in science public policy and as an original author of Molecular Biology of the Cell. He is noted for his study of the protein complexes that enable chromosome replication when living cells divide. Bruce was Editor-in-Chief of the journal Science and served as United States Science Envoy to Pakistan and Indonesia. He was the president of the National Academy of Sciences from 1993 to 2005 where he was instrumental in developing the landmark National Science Education standards that have been implemented in school systems nationwide. Bruce has earned many honors and awards, including 14 honorary degrees, is an Overseer at Harvard University and is past President of the American Society of Cell Biology. He is currently a trustee of the Gordon and Betty Moore Foundation in Palo Alto, California.
John Danforth, JD
John earned his law degree from Columbia University and has extensive experience in intellectual property and mergers & acquisitions. Currently self-employed as a legal services consultant, he has held Senior VP and General Counsel positions with Silicon Valley corporations, including Rambus, Niku, Creative Technology Ltd, and Morrison & Forester LLP.
Peter Frishauf, MS
Peter is the founder of Medscape, a web resource used by millions of physicians and other health professionals, now owned by WebMD. It features original peer-reviewed medical journal articles, CME, daily medical news, major conference coverage, and drug information. As a journalist and serial publishing entrepreneur, Peter founded two other medical information companies, including SCP Communications. He is currently director of Crossix Solutions, Inc. (where he serves as Chair); and Context Matters. He serves as an advisor to MedPage Today, a breaking medical news site. A complete bio is here.
Rebecca Kennison, MA
Rebecca is one of the two Principals at K|N Consultants. Prior to working full time at K|N, she was the founding director of the Center for Digital Research and Scholarship, a division of the Columbia University Libraries/Information Services, where for nearly 8 years she was responsible for developing programs to facilitate scholarly research and the communication of that research through technology solutions. Rebecca has worked primarily in the scholarly publishing industry, including production leadership roles at Cell Press, Blackwell Publishing (now Wiley-Blackwell), and the open-access publisher Public Library of Science (PLOS).
Laurence Marton, MD
Laurence is a leading expert in cell growth and drug development, and serves as a consultant to industry and to nonprofit, governmental, and academic institutions. In the nonprofit sector, he serves on the Board of Trustees of the American Association for Cancer Research Foundation, and on the Board of Directors of Cancer Commons and of the Bay Area American Committee for the Weizmann Institute of Science. In the for-profit sector, he serves on the Board of Directors of TOMA Biosciences, RenovoRx, Microsonic Systems and Pathologica. Earlier, Laurence was Dean of the University of Wisconsin Medical School and chaired the Department of Laboratory Medicine at UCSF, where he was a Professor in the Departments of Laboratory Medicine and Neurological Surgery.
Sarah Greene, MSc
Founder & CEO
Sarah is a biologist and new media entrepreneur with a track record of disrupting scholarly publishing processes. She most recently served as Executive Director of Cancer Commons, where she developed online communities, content, and apps for researchers and patients. Previously she was editor-in-chief of The Scientist magazine and its parent, Faculty of 1000, a post-publication peer review service in London. Over the years Sarah founded three successful startups acquired by Wiley (Current Protocols), Elsevier (HMS Beagle web magazine and BioMedNet), and Thomson Health (Praxis Press; Best Practice of Medicine). She was a co-founder of the Society for Participatory Medicine and managing editor of its Journal of Participatory Medicine. Sarah also developed websites with original features and content for the New York Academy of Sciences and the New York Times-Health, and was chief content officer at Keas, Inc. Follow her on Twitter @sgreene24 and Linkedin.
Emily Warner, JD
Director of Operations
Emily is an attorney who has worked with several organizations that bring social change principles to the healthcare sphere. Most recently, Emily served as the Director of Health Policy and Payment Innovation at the Center to Advance Palliative Care, where she led several strategic initiatives designed to change standards and improve delivery systems in healthcare. Prior to her role at CAPC, she served as in-house counsel at the Institute for Integrative Nutrition, a rapidly-growing nutrition and wellness school that aims to create broad change in preventative health perspectives and behavior. Emily holds a JD from the Georgetown University Law Center.
Emma Shtivelman, PhD
Emma is a molecular and cell biologist with extensive experience in cancer biology. She has in-depth understanding of cancer signal transduction and metabolism, cancer models in vitro and in vivo, target and drug discovery and validation, assay development, and preclinical research. She has technical expertise in numerous modern methodologies employed to understand the molecular basis of human malignancies and advance preclinical and clinical research. Emma received her PhD in molecular biology from the Weizmann Institute of Science where she identified the fused transcript between two cellular genes, BCR and ABL in chronic myelogenous leukemia (CML), the first demonstration of an oncogenic gene product derived from a chromosomal translocation. As a postdoctoral fellow at the University of California, San Francisco (UCSF), she characterized the molecular consequences of chromosomal translocations in Burkitt lymphoma and identified gene products relevant to the pathogenesis of neuroblastoma. She worked at Systemix on establishing a novel SCID-hu metastasis model to enable the in vivo analysis of human tumor metastasis. She continued her research activity at the UCSF Cancer Center analyzing deregulation of signal transduction pathways in human cancer and the molecular underpinnings of metastatic progression. Before joining Cancer Commons, Emma worked at BioNovo, Inc., researching new drugs that selectively disrupt metabolism of breast and pancreatic cancers by targeting their metabolic preferences.
Rich is an experienced corporate strategist and business development executive in the information and publishing industries. Most recently, he served as VP-Practice Leader for Science, Technology & Healthcare at Outsell, Inc., a top information industry consultancy, serving leading scientific and technical publishers. He has held senior business development roles at multiple startups, including Healthline, HighBeam Research and iSyndicate, creating alliances with companies in healthcare and media, including Microsoft, WebMD and Time Inc.’s Health.com.
Evelyn Strauss, PhD
Evelyn is a biologist-turned-journalist who has extensive experience launching and running innovative websites for researchers. She earned a PhD in biochemistry at the University of California, San Francisco, and studied bacterial pathogens as a postdoctoral fellow at Stanford. She has written for Scientific American, Health, WebMD, HHMI Bulletin, the Pew Charitable Trusts, and the American Academy of Microbiology. She was a contributing correspondent for Science between 1999 and 2009 and has been the official citation writer for the Albert and Mary Lasker Foundation since 2000. Evelyn teaches science journalism and grant writing at the University of California, Santa Cruz, and has held several leadership positions in startup enterprises at the intersection of science, communication, and community building. She co-created Science’s website on aging (Science of Aging Knowledge Environment, SAGE KE) and ran its news operation, and she served as the founding executive director of the New York Academy of Science’s web-based initiative, Scientists Without Borders, that aims to improve quality of life in the developing world by mobilizing and coordinating science-based activities. Most recently, she was the founding executive editor of the Multiple Sclerosis Discovery Forum, where she conceived and created online tools, articles, and other resources for investigators.
Ash Ayman Shairzay
Since 1998, Ash has specialized in solving the complex information design challenges presented by content-rich websites. A philosopher by education (New York University), Ash has been able to translate a pragmatist’s aesthetic to the design of Webby Award-winning user interfaces. Information design is most successful when it’s inconspicuous. This is especially true for the multifaceted nature of science and medicine, the industry in which Ash has spent the majority of his career. Ash has collaborated often with Rapid Science Founder & CEO Sarah Greene, from Praxis.md, to the New York Academy of Sciences, The Scientist, Faculty of 1000, Cancer Commons, and now Rapid Science. Ash has also worked with Elsevier, Ford, the Michael J Fox Foundation, New York University, Nissan, Smart Patients, and Time Inc., to name a few.